Publications by authors named "Marco Antonio Sotomayor-Sobrino"

Article Synopsis
  • Chemotherapy is a common treatment for cancer but can lead to significant side effects, notably chemotherapy-induced neuropathic pain (CINP), which affects about 68.1% of patients within a month of treatment.
  • A study conducted at Mexico's National Institute of Cancerology found that 30.9% of cancer patients experienced CINP, with the average pain level remaining relatively unchanged from their first visit to the end of treatment.
  • Patients treated with certain chemotherapy drugs like paclitaxel and platin showed a higher risk of developing CINP, emphasizing the need for improved risk assessment and pain management strategies in cancer care.
View Article and Find Full Text PDF

Multiple sclerosis-related neurobehavioral abnormalities are one of the main components of disability in this disease. The same pathological processes that explain demyelination periods and neurodegeneration also allow the comprehension of neurobehavioral abnormalities. Inflammation in the central nervous system caused by cells of the immune system, especially lymphocytes, and by resident cells, such as astrocytes and microglia, directly modulate neurotransmission and synaptic physiology, resulting in behavioral changes (such as sickness behavior) and amplifying the degenerative mechanisms that occur in multiple sclerosis.

View Article and Find Full Text PDF

Introduction: Ceftriaxone (CFX) and clavulanic acid (CA) are 2 β-lactam molecules widely used as antibiotics. However, several reports of their antiallodynic properties have been published in recent years. Although this effect has been considered mostly due to a GLT1 overexpression, these molecules have also been proven to induce direct immunomodulation.

View Article and Find Full Text PDF

Background: Beta-lactam molecules are a family of drugs commonly used for their antibiotic properties; however, recent research has shown that several members of this group present a large number of other effects such as neuroprotective, antioxidant, analgesic or immunomodulatory capabilities. These properties have been used in both preclinical and clinical studies in different diseases such as hypoxic neuronal damage or acute and chronic pain. The present work briefly reviews the antibiotic effect of these molecules, and will then focus specially on the non-antibiotic effects of three beta-lactam subfamilies: penicillins, cephalosporins and beta lactamase inhibitors, each of which have different molecular structure and pharmacokinetics and therefore have several potential clinical applications.

View Article and Find Full Text PDF